Hygromycin B is a fda approved antibiotic food additive for swine and poultry Hygromycin B is an antibiotic produced by the bacterium Streptomyces hygroscopicus. It is an aminoglycoside that kills bacteria, fungi and higher eukaryotic cells by inhibiting protein synthesis.
Hygromycin B is a well-established aminoglycoside antibiotic widely utilized in molecular biology and biotechnology research. Characterized by its potent inhibitory effect on protein synthesis in prokaryotic and eukaryotic cells, Hygromycin B stands out for its robust selection capabilities, making it a preferred agent for maintaining and isolating genetically modified organisms. Its water solubility and stability in various media have contributed to its versatility, while its mode of action—interfering with ribosomal translocation—ensures effectiveness across a broad spectrum of experimental systems. The compound's compatibility with a range of cell types and its ability to function under diverse culture conditions further enhance its utility in advanced research settings.
Gene Selection and Maintenance: In genetic engineering and cell line development, Hygromycin B is a critical tool for the selection and maintenance of cells that have been successfully transfected or transformed with a hygromycin resistance gene. Researchers commonly incorporate a hygromycin resistance cassette into plasmids or vectors, allowing only those cells that have integrated the desired genetic material to survive in the presence of the antibiotic. This positive selection strategy streamlines the identification of stable clones, ensuring that subsequent analyses and experiments are conducted on populations with the intended genetic modification. The reliability of Hygromycin B in this context reduces the time and resources needed for screening, thereby accelerating the development of genetically engineered models.
Transgenic Organism Generation: The use of Hygromycin B extends to the creation of transgenic plants, fungi, and animal models. By applying the compound to tissues or cultures exposed to transformation protocols, researchers can eliminate non-transformed cells and selectively propagate those with successful gene integration. In plant biotechnology, for instance, hygromycin selection is instrumental in generating transgenic crops with improved traits, such as disease resistance or enhanced nutritional profiles. Similarly, in fungal genetics, it enables the efficient isolation of strains with targeted gene disruptions or insertions, facilitating functional genomics studies and the exploration of gene function in complex biological processes.
Protein Expression Systems: Hygromycin B plays a pivotal role in the establishment and maintenance of stable protein expression systems in both prokaryotic and eukaryotic hosts. When used in conjunction with expression vectors harboring a resistance gene, it allows for the continuous selection of high-yielding clones in bacterial, yeast, insect, or mammalian cell cultures. This application is particularly valuable in recombinant protein production, where consistent and robust expression of the target protein is essential for downstream purification and characterization. The ability to maintain selective pressure ensures that only cells retaining the desired construct persist over extended culture periods, thereby improving the reproducibility and scalability of protein manufacturing processes.
Functional Genomics and Gene Knockout Studies: In functional genomics, Hygromycin B is frequently employed to facilitate gene knockout, knock-in, or conditional gene expression experiments. By integrating selectable markers into specific genomic loci, researchers can use the antibiotic to enrich for cells with precise genetic alterations. This approach is fundamental in dissecting gene function, elucidating signaling pathways, and modeling disease mechanisms at the cellular and organismal levels. The high efficiency of selection provided by Hygromycin B minimizes background noise from non-targeted events, enabling more accurate interpretation of genetic manipulations and their phenotypic consequences.
Viral Vector and Genome Editing Technologies: The utility of Hygromycin B extends into advanced genome editing and viral vector systems. In lentiviral or retroviral transduction protocols, hygromycin selection is routinely used to isolate stably transduced cells, ensuring that downstream experiments are conducted with populations expressing the gene of interest or genome-editing machinery. This is particularly important in CRISPR/Cas9-mediated editing, where selection for hygromycin resistance can greatly enhance the efficiency of generating isogenic cell lines or engineered models. The antibiotic's compatibility with various delivery platforms and cell types makes it an indispensable component of modern genetic engineering workflows, supporting innovations in gene therapy research, functional studies, and synthetic biology.
Microbial Contamination Control: Beyond its role in genetic selection, Hygromycin B is also leveraged in research environments to control microbial contamination in cell cultures and fermentations. Its broad-spectrum activity against bacteria and fungi helps maintain the integrity of experimental systems, especially when working with sensitive or slow-growing cultures. By incorporating the antibiotic into culture media, researchers can suppress unwanted microbial growth, thereby preserving the fidelity of experimental results and reducing the risk of cross-contamination. This application is particularly valuable in long-term culture experiments, large-scale fermentations, and environments where aseptic conditions are challenging to maintain, highlighting the compound's multifaceted utility in laboratory research and bioprocessing.
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
5. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More